uniQure N.V. (QURE) stock: key figures, P/E, revenue and dividend
Health Care · ISIN USN900641010
uniQure N.V. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 16.10 m USD |
| Gross profit | 14.41 m USD |
| Operating income | -185.35 m USD |
| EBIT | -148.31 m USD |
| Net income | -198.97 m USD |
| Diluted EPS – continuing operations | -3.46 USD |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About uniQure N.V.
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
More stocks
- Sanoma Oyj (SANOMA.HE)
- Xiamen Kingdomway Group Co (002626.SZ)
- Cloetta AB (CLA B.ST)
- 3R Petroleum Oleo E Gas SA Ordinary Shares (BRAV3.SA)
- Anhui Kouzi Distillery Co Ltd (603589.SS)
- Kosmos Energy Ltd. (KOS)
- Exzeo Group, Inc. (XZO)
- Lu-Ve SpA (LUVE.MI)
- Solar Applied Materials Technology (1785.TWO)
- Ruentex Engineering & Construction Co Ltd (2597.TW)
- Bandwidth Inc. (BAND)
- PATHWARD FINANCIAL, INC. (CASH)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.